Takeshi Katayoshi
Takeshi Katayoshi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Kentaro Tsuji-Naito
DHC Corporation Laboratories, Division 2, Chiba, Japan
5 shared publications - Takahisa Nakajo
DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba, 261-0025, Japan
5 shared publications - Natsuko Kitajima
DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba, 261-0025, Japan
4 shared publications Kentaro Tsuji-Naito
DHC Corporation Laboratories, Chiba, Japan
3 shared publicationsNatsuko Kitajima
DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba, 261-0025, Japan
2 shared publicationsTakahisa Nakajo
DHC Corporation Laboratories, Chiba, Japan
2 shared publications
Latest Publications
- Open Access
- 20 May 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (10) , e71187
Intracellular NAD + Depletion Increases Prostanoid Production via p38/ COX2 Signalling in FK866 ‐Induced Senescent Human Umbilical Vein Endothelial Cells
Vascular endothelial cells maintain vascular homeostasis by releasing mediators with vasoconstrictive and vasorelaxant effects. Prostanoids are bioactive substances synthesised by cyclooxygenase2 (COX2); they preserve vascular function and can increase the risk of cardiovascular disease (CVD) associated with ageing. Age‐related reductions in nicotinamide adenine dinucleotide (NAD + ) have been implicated in CVD pathogenesis. However, the relationship between intracellular NAD + levels and prostanoid production in vascular endothelial cells is unclear. Herein, reduced intracellular NAD + levels upregulated COX2 protein expression by activating the p38 mitogen‐activated protein kinase (MAPK) signalling pathway, increasing the production of prostaglandin F 1α (PGF 1α ) and thromboxane B 2 (TXB 2 ) in human umbilical vein endothelial cells (HUVECs). Treatment with the nicotinamide phosphoribosyltransferase (NAMPT) inhibitor, FK866, decreased intracellular NAD + levels, induced a cellular senescence‐like phenotype characterised by the suppression of cell proliferation without cell death and promoted PGF 1α and TXB 2 production in HUVECs. FK866 treatment increased phosphorylated p38 and COX2 protein levels, whereas treatment with the p38 inhibitor, PD169316, suppressed the FK866‐induced increase in COX2 expression. Supplementation with nicotinamide mononucleotide (NMN), a precursor of NAD + , following FK866 treatment restored intracellular NAD + levels, reduced the cellular senescence‐like phenotype and attenuated the production of PGF 1α and TXB 2 . These results suggest that intracellular NAD + appears to regulate prostanoid production in HUVECs under conditions of acute depletion.
- 20 May 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (10) , e71187
Open AccessIntracellular NAD + Depletion Increases Prostanoid Production via p38/ COX2 Signalling in FK866 ‐Induced Senescent Human Umbilical Vein Endothelial Cells
Vascular endothelial cells maintain vascular homeostasis by releasing mediators with vasoconstrictive and vasorelaxant effects. Prostanoids are bioactive substances synthesised by cyclooxygenase2 (COX2); they preserve vascular function and can increase the risk of cardiovascular disease (CVD) associated with ageing. Age‐related reductions in nicotinamide adenine dinucleotide (NAD + ) have been implicated in CVD pathogenesis. However, the relationship between intracellular NAD + levels and prostanoid production in vascular endothelial cells is unclear. Herein, reduced intracellular NAD + levels upregulated COX2 protein expression by activating the p38 mitogen‐activated protein kinase (MAPK) signalling pathway, increasing the production of prostaglandin F 1α (PGF 1α ) and thromboxane B 2 (TXB 2 ) in human umbilical vein endothelial cells (HUVECs). Treatment with the nicotinamide phosphoribosyltransferase (NAMPT) inhibitor, FK866, decreased intracellular NAD + levels, induced a cellular senescence‐like phenotype characterised by the suppression of cell proliferation without cell death and promoted PGF 1α and TXB 2 production in HUVECs. FK866 treatment increased phosphorylated p38 and COX2 protein levels, whereas treatment with the p38 inhibitor, PD169316, suppressed the FK866‐induced increase in COX2 expression. Supplementation with nicotinamide mononucleotide (NMN), a precursor of NAD + , following FK866 treatment restored intracellular NAD + levels, reduced the cellular senescence‐like phenotype and attenuated the production of PGF 1α and TXB 2 . These results suggest that intracellular NAD + appears to regulate prostanoid production in HUVECs under conditions of acute depletion.
- Open Access
- 6 July 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 731, 150371
NAD+ overconsumption by poly (ADP-ribose) polymerase (PARP) under oxidative stress induces cytoskeletal disruption in vascular endothelial cell
- 6 July 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 731, 150371
Open AccessNAD+ overconsumption by poly (ADP-ribose) polymerase (PARP) under oxidative stress induces cytoskeletal disruption in vascular endothelial cell
- Open Access
- 27 October 2023
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 36, 101561
Nucleotide-binding oligomerization domain protein-1 is expressed and involved in the inflammatory response in human sebocytes
- 27 October 2023
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 36, 101561
Open AccessNucleotide-binding oligomerization domain protein-1 is expressed and involved in the inflammatory response in human sebocytes
- 26 August 2023
- Published by Elsevier in Toxicology in Vitro
- Vol. 93, 105683
Nicotinamide mononucleotide inhibits oxidative stress-induced damage in a SIRT1/NQO-1-dependent manner
- 26 August 2023
- Published by Elsevier in Toxicology in Vitro
- Vol. 93, 105683
Nicotinamide mononucleotide inhibits oxidative stress-induced damage in a SIRT1/NQO-1-dependent manner
- Open Access
- 9 November 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-10
Porcine placental extract increase the cellular NAD levels in human epidermal keratinocytes
Nicotinamide adenine dinucleotide (NAD) is an essential cofactor for numerous enzymes involved in energy metabolism. Because decreasing NAD levels is a common hallmark of the aging process in various tissues and organs, maintaining NAD levels has recently been of interest for the prevention of aging and age-related diseases. Although placental extract (PE) are known to possess several anti-aging effects, the NAD-boosting activity of PE remains unknown. In this study, we found that porcine PE (PPE) significantly increased intracellular NAD levels in normal human epidermal keratinocytes (NHEKs). PPE also attenuated the NAD depletion induced by FK866, an inhibitor of nicotinamide phosphoribosyltransferase (NAMPT). Interestingly, only the fraction containing nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), and nicotinamide (NAM) restored NAD content in NHEKs in the absence of NAMPT activity. These results suggest that PPE increases intracellular NAD by providing NAD precursors such as NMN, NR, and NAM. Finally, we showed that the application of PPE to the stratum corneum of the reconstructed human epidermis significantly ameliorated FK866-induced NAD depletion, suggesting that topical PPE may be helpful for increasing skin NAD levels. This is the first study to report the novel biological activity of PE as an NAD booster in human epidermal cells.
- 9 November 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-10
Open AccessPorcine placental extract increase the cellular NAD levels in human epidermal keratinocytes
Nicotinamide adenine dinucleotide (NAD) is an essential cofactor for numerous enzymes involved in energy metabolism. Because decreasing NAD levels is a common hallmark of the aging process in various tissues and organs, maintaining NAD levels has recently been of interest for the prevention of aging and age-related diseases. Although placental extract (PE) are known to possess several anti-aging effects, the NAD-boosting activity of PE remains unknown. In this study, we found that porcine PE (PPE) significantly increased intracellular NAD levels in normal human epidermal keratinocytes (NHEKs). PPE also attenuated the NAD depletion induced by FK866, an inhibitor of nicotinamide phosphoribosyltransferase (NAMPT). Interestingly, only the fraction containing nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), and nicotinamide (NAM) restored NAD content in NHEKs in the absence of NAMPT activity. These results suggest that PPE increases intracellular NAD by providing NAD precursors such as NMN, NR, and NAM. Finally, we showed that the application of PPE to the stratum corneum of the reconstructed human epidermis significantly ameliorated FK866-induced NAD depletion, suggesting that topical PPE may be helpful for increasing skin NAD levels. This is the first study to report the novel biological activity of PE as an NAD booster in human epidermal cells.
- Open Access
- 1 December 2021
- Published by Elsevier in Redox Biology
- Vol. 48, 102203
1,25-Dihydroxyvitamin D3 attenuates IL-1β secretion by suppressing NLRP1 inflammasome activation by upregulating the NRF2-HO-1 pathway in epidermal keratinocytes
- 1 December 2021
- Published by Elsevier in Redox Biology
- Vol. 48, 102203
Open Access1,25-Dihydroxyvitamin D3 attenuates IL-1β secretion by suppressing NLRP1 inflammasome activation by upregulating the NRF2-HO-1 pathway in epidermal keratinocytes
- 8 September 2021
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 85 (11) , 2232-2240
Low-molecular-weight whey proteins promote collagen production in dermal fibroblasts via the TGF-β receptor/Smad pathway
Whey proteins (WPs) reportedly enhance cutaneous tissue regeneration in in vivo studies. However, the underlying mechanisms of such regenerative processes are poorly understood. In this study, we show that low-molecular-weight WPs (LMWPs; 1-30 kDa) accelerate the dermal collagen production via the transforming growth factor β receptor (TβR)/Smad pathway. We showed that LMWPs increased type I and III collagen expression in normal human dermal fibroblasts. Moreover, LMWPs rapidly induced Smad protein phosphorylation and nuclear translocation. Notably, type I TβR/Smad signaling inhibitor treatment or type II TβR siRNA knockdown blocked the LMWP-induced type I collagen expression. To identify the active components, we fractionated LMWPs and identified β-lactoglobulin and α-lactalbumin as potential TβR/Smad signaling inducers. Our findings unravel novel biological functions of WPs, involving the TβR/Smad-dependent induction of dermal collagen synthesis, highlighting the therapeutic potential of LMWPs in wound healing.
- 8 September 2021
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 85 (11) , 2232-2240
Low-molecular-weight whey proteins promote collagen production in dermal fibroblasts via the TGF-β receptor/Smad pathway
Whey proteins (WPs) reportedly enhance cutaneous tissue regeneration in in vivo studies. However, the underlying mechanisms of such regenerative processes are poorly understood. In this study, we show that low-molecular-weight WPs (LMWPs; 1-30 kDa) accelerate the dermal collagen production via the transforming growth factor β receptor (TβR)/Smad pathway. We showed that LMWPs increased type I and III collagen expression in normal human dermal fibroblasts. Moreover, LMWPs rapidly induced Smad protein phosphorylation and nuclear translocation. Notably, type I TβR/Smad signaling inhibitor treatment or type II TβR siRNA knockdown blocked the LMWP-induced type I collagen expression. To identify the active components, we fractionated LMWPs and identified β-lactoglobulin and α-lactalbumin as potential TβR/Smad signaling inducers. Our findings unravel novel biological functions of WPs, involving the TβR/Smad-dependent induction of dermal collagen synthesis, highlighting the therapeutic potential of LMWPs in wound healing.
- 1 August 2021
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 221, 112238
Restoring NAD+ by NAMPT is essential for the SIRT1/p53-mediated survival of UVA- and UVB-irradiated epidermal keratinocytes
- 1 August 2021
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 221, 112238
Restoring NAD+ by NAMPT is essential for the SIRT1/p53-mediated survival of UVA- and UVB-irradiated epidermal keratinocytes